Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 98 articles:
HTML format
Text format



Single Articles


    August 2018
  1. KROON HM, van der Bol WD, Tonks KT, Hong AM, et al
    Treatment of Clinically Positive Cervical Lymph Nodes by Limited Local Node Excision and Adjuvant Radiotherapy in Melanoma Patients with Major Comorbidities.
    Ann Surg Oncol. 2018 Aug 16. pii: 10.1245/s10434-018-6692.
    PubMed     Text format     Abstract available


  2. GERSHENWALD JE, Scolyer RA
    Correction to: Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
    Ann Surg Oncol. 2018 Aug 13. pii: 10.1245/s10434-018-6689.
    PubMed     Text format     Abstract available


  3. LEONG SP, Wu M, Lu Y, Torre DM, et al
    Intraoperative Imaging with a Portable Gamma Camera May Reduce the False-Negative Rate for Melanoma Sentinel Lymph Node Surgery.
    Ann Surg Oncol. 2018 Aug 13. pii: 10.1245/s10434-018-6685.
    PubMed     Text format     Abstract available


    July 2018
  4. WADE RG, Robinson AV, Lo MCI, Keeble C, et al
    Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study.
    Ann Surg Oncol. 2018 Jul 31. pii: 10.1245/s10434-018-6660.
    PubMed     Text format     Abstract available


  5. SINNAMON AJ, Song Y, Sharon CE, Yang YX, et al
    Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Ann Surg Oncol. 2018 Jul 24. pii: 10.1245/s10434-018-6647.
    PubMed     Text format     Abstract available


    June 2018
  6. MONCRIEFF MD, Gyorki D, Saw R, Spillane AJ, et al
    Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
    Ann Surg Oncol. 2018 Jun 26. pii: 10.1245/s10434-018-6612.
    PubMed     Text format     Abstract available


    May 2018
  7. MONCRIEFF MD, Gyorki D, Saw R, Spillane AJ, et al
    1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
    Ann Surg Oncol. 2018 May 30. pii: 10.1245/s10434-018-6470.
    PubMed     Text format     Abstract available


  8. GERSHENWALD JE, Scolyer RA
    Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond.
    Ann Surg Oncol. 2018 May 30. pii: 10.1245/s10434-018-6513.
    PubMed     Text format    


  9. KATSARELIAS D, Radbo E, Ben-Shabat I, Mattsson J, et al
    The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion.
    Ann Surg Oncol. 2018 May 15. pii: 10.1245/s10434-018-6459.
    PubMed     Text format     Abstract available


  10. BALCH CM
    Revolutionary Advances in Immunotherapy for Melanoma Are Coming into the Surgical Arena: Are We Ready?
    Ann Surg Oncol. 2018 May 11. pii: 10.1245/s10434-018-6516.
    PubMed     Text format    


  11. CUI C, Lian B, Zhou L, Song X, et al
    Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients.
    Ann Surg Oncol. 2018 May 10. pii: 10.1245/s10434-018-6503.
    PubMed     Text format     Abstract available


    April 2018
  12. PARK JS, Ng KS, Saw RPM, Thompson JF, et al
    Metastatic Melanoma to the Colon, Rectum, and Anus: A 50-Year Experience.
    Ann Surg Oncol. 2018 Apr 24. pii: 10.1245/s10434-018-6451.
    PubMed     Text format     Abstract available


  13. AMIT M, Tam S, Abdelmeguid AS, Kupferman ME, et al
    Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
    Ann Surg Oncol. 2018 Apr 6. pii: 10.1245/s10434-018-6465.
    PubMed     Text format     Abstract available


    March 2018
  14. EGGER ME, Xiao D, Hao H, Kimbrough CW, et al
    Unique Genes in Tumor-Positive Sentinel Lymph Nodes Associated with Nonsentinel Lymph Node Metastases in Melanoma.
    Ann Surg Oncol. 2018 Mar 1. pii: 10.1245/s10434-018-6377.
    PubMed     Text format     Abstract available


    February 2018
  15. ZABOR EC, Coit D, Gershenwald JE, McMasters KM, et al
    Variability in Predictions from Online Tools: A Demonstration Using Internet-Based Melanoma Predictors.
    Ann Surg Oncol. 2018 Feb 22. pii: 10.1245/s10434-018-6370.
    PubMed     Text format     Abstract available


  16. BELLO DM, Ariyan CE
    Adjuvant Therapy in the Treatment of Melanoma.
    Ann Surg Oncol. 2018 Feb 21. pii: 10.1245/s10434-018-6376.
    PubMed     Text format    


    January 2018
  17. MURTHA TD, Han G, Han D
    Predictors for Use of Sentinel Node Biopsy and the Association with Improved Survival in Melanoma Patients Who Have Nodal Staging.
    Ann Surg Oncol. 2018 Jan 24. pii: 10.1245/s10434-018-6348.
    PubMed     Text format     Abstract available


  18. TRINH BB, Chapman BC, Gleisner A, Kwak JJ, et al
    SPECT/CT Adds Distinct Lymph Node Basins and Influences Radiologic Findings and Surgical Approach for Sentinel Lymph Node Biopsy in Head and Neck Melanoma.
    Ann Surg Oncol. 2018 Jan 12. pii: 10.1245/s10434-017-6298.
    PubMed     Text format     Abstract available


  19. LO SN, Scolyer RA, Thompson JF
    Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk and Lower-Risk Tumors.
    Ann Surg Oncol. 2018 Jan 12. pii: 10.1245/s10434-017-6325.
    PubMed     Text format     Abstract available


  20. FARIES MB
    Completing the Dissection in Melanoma: Increasing Decision Precision.
    Ann Surg Oncol. 2018 Jan 4. pii: 10.1245/s10434-017-6330.
    PubMed     Text format    


  21. READ RL, Madronio CM, Cust AE, Goumas C, et al
    Follow-Up Recommendations after Diagnosis of Primary Cutaneous Melanoma: A Population-Based Study in New South Wales, Australia.
    Ann Surg Oncol. 2018 Jan 3. pii: 10.1245/s10434-017-6319.
    PubMed     Text format     Abstract available


  22. SHIRAI K, Wong SL
    Melanoma Surveillance Strategies: Different Approaches to a Shared Goal.
    Ann Surg Oncol. 2018 Jan 2. pii: 10.1245/s10434-017-6321.
    PubMed     Text format    


    December 2017
  23. LI S, Sheng X, Si L, Cui C, et al
    Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.
    Ann Surg Oncol. 2017 Dec 21. pii: 10.1245/s10434-017-6256.
    PubMed     Text format     Abstract available


  24. WONG SL, Faries MB, Kennedy EB, Agarwala SS, et al
    Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update.
    Ann Surg Oncol. 2017 Dec 13. pii: 10.1245/s10434-017-6267.
    PubMed     Text format     Abstract available


    November 2017
  25. POSTLEWAIT LM, Farley CR, Seamens AM, Le N, et al
    Morbidity and Outcomes Following Axillary Lymphadenectomy for Melanoma: Weighing the Risk of Surgery in the Era of MSLT-II.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6242.
    PubMed     Text format     Abstract available


  26. VOIT CA, van Akkooi ACJ, Catalano O, Eggermont AMM, et al
    Pre-SN Ultrasound-FNAC can be Sensitive for Lymph Node Metastases in Melanoma Patients if Performed with the Use of the Berlin Criteria.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6230.
    PubMed     Text format    


  27. CHAI C, Szabunio M, Cook C, Zager J, et al
    Pre-SN Ultrasound-FNAC for Lymph Node Metastases in Melanoma Patients: A Reply.
    Ann Surg Oncol. 2017 Nov 13. doi: 10.1245/s10434-017-6231.
    PubMed     Text format    


  28. MADU MF, van de Wiel B, van Akkooi ACJ
    Comment: Detailed Pathologic Examination of Completion Node Dissection Specimens and Outcome for Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.
    Ann Surg Oncol. 2017 Nov 7. doi: 10.1245/s10434-017-6169.
    PubMed     Text format    


  29. CRAWFORD AB, Nessim C, Weaver J, van Walraven C, et al
    Wait Times for Melanoma Surgery: Is There an Association with Overall Survival?
    Ann Surg Oncol. 2017 Nov 3. doi: 10.1245/s10434-017-6146.
    PubMed     Text format     Abstract available


    October 2017
  30. HOLTKAMP LHJ, Wang S, Wilmott JS, Madore J, et al
    Reply to comment on: Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (< 0.1 mm) Sentinel Lymph Node Metastases.
    Ann Surg Oncol. 2017 Oct 27. doi: 10.1245/s10434-017-6170.
    PubMed     Text format    


  31. ROSSI CR, Mocellin S, Campana LG, Borgognoni L, et al
    Prediction of Non-sentinel Node Status in Patients with Melanoma and Positive Sentinel Node Biopsy: An Italian Melanoma Intergroup (IMI) Study.
    Ann Surg Oncol. 2017 Oct 24. doi: 10.1245/s10434-017-6143.
    PubMed     Text format     Abstract available


  32. FARIES MB, Mozzillo N, Kashani-Sabet M, Thompson JF, et al
    Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases.
    Ann Surg Oncol. 2017 Oct 10. doi: 10.1245/s10434-017-6072.
    PubMed     Text format     Abstract available


    August 2017
  33. KROON HM, Coventry BJ, Giles MH, Henderson MA, et al
    Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study.
    Ann Surg Oncol. 2017 Aug 10. doi: 10.1245/s10434-017-6046.
    PubMed     Text format     Abstract available


  34. POSTLEWAIT LM, Farley CR, Diller ML, Martin B, et al
    A Minimally Invasive Approach for Inguinal Lymphadenectomy in Melanoma and Genitourinary Malignancy: Long-Term Outcomes in an Attempted Randomized Control Trial.
    Ann Surg Oncol. 2017 Aug 2. doi: 10.1245/s10434-017-5971.
    PubMed     Text format     Abstract available


    May 2017
  35. VAREY AHR, Madronio CM, Cust AE, Goumas C, et al
    Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia.
    Ann Surg Oncol. 2017 May 25. doi: 10.1245/s10434-017-5890.
    PubMed     Text format     Abstract available


  36. KANG R, Wong SL
    Melanoma Surgery: Why Don't We Let the Guidelines Guide Practice?
    Ann Surg Oncol. 2017 May 22. doi: 10.1245/s10434-017-5891.
    PubMed     Text format    


  37. BEASLEY GM, Hu Y, Youngwirth L, Scheri RP, et al
    Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.
    Ann Surg Oncol. 2017 May 15. doi: 10.1245/s10434-017-5883.
    PubMed     Text format     Abstract available


    April 2017
  38. WRIGHT GP, Marsh JW, Varma MK, Doherty MG, et al
    Liver Resection After Selective Internal Radiation Therapy with Yttrium-90 is Safe and Feasible: A Bi-institutional Analysis.
    Ann Surg Oncol. 2017;24:906-913.
    PubMed     Text format     Abstract available


    March 2017
  39. MORTON RL, Tran A, Vessey JY, Rowbotham N, et al
    Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications.
    Ann Surg Oncol. 2017 Mar 20. doi: 10.1245/s10434-017-5842.
    PubMed     Text format     Abstract available


  40. DAVIS JL, Langan RC, Panageas KS, Zheng J, et al
    Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.
    Ann Surg Oncol. 2017 Mar 16. doi: 10.1245/s10434-017-5836.
    PubMed     Text format     Abstract available


    February 2017
  41. JONES MS, Jones PC, Stern SL, Elashoff D, et al
    The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma.
    Ann Surg Oncol. 2017 Feb 21. doi: 10.1245/s10434-017-5775.
    PubMed     Text format     Abstract available


  42. MADU MF, Deken MM, van der Hage JA, Jozwiak K, et al
    Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.
    Ann Surg Oncol. 2017 Feb 10. doi: 10.1245/s10434-017-5803.
    PubMed     Text format     Abstract available


  43. DOEPKER MP, Yamamoto M, Applebaum MA, Patel NU, et al
    Comparison of Single-Photon Emission Computed Tomography-Computed Tomography (SPECT/CT) and Conventional Planar Lymphoscintigraphy for Sentinel Node Localization in Patients with Cutaneous Malignancies.
    Ann Surg Oncol. 2017;24:355-361.
    PubMed     Text format     Abstract available


  44. FAUT M, Heidema RM, Hoekstra HJ, van Ginkel RJ, et al
    Morbidity After Inguinal Lymph Node Dissections: It Is Time for a Change.
    Ann Surg Oncol. 2017;24:330-339.
    PubMed     Text format     Abstract available


  45. LATCHANA N, Del Campo SE, Grignol VP, Clark JR, et al
    Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
    Ann Surg Oncol. 2017;24:347-354.
    PubMed     Text format     Abstract available


    January 2017
  46. PARK TS, Phan GQ, Yang JC, Kammula U, et al
    Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.
    Ann Surg Oncol. 2017 Jan 31. doi: 10.1245/s10434-017-5768.
    PubMed     Text format     Abstract available


  47. CROOKES TR, Scolyer RA, Lo S, Drummond M, et al
    Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.
    Ann Surg Oncol. 2017 Jan 27. doi: 10.1245/s10434-016-5723.
    PubMed     Text format     Abstract available


  48. BHUTIANI N, Egger ME, McMasters KM
    Optimizing Follow-up Assessment of Patients with Cutaneous Melanoma.
    Ann Surg Oncol. 2017 Jan 24. doi: 10.1245/s10434-017-5771.
    PubMed     Text format    


  49. STEWART CL, Gleisner A, Kwak J, Chapman B, et al
    Implications of Sentinel Lymph Node Drainage to Multiple Basins in Head and Neck Melanoma.
    Ann Surg Oncol. 2017 Jan 5. doi: 10.1245/s10434-016-5744.
    PubMed     Text format     Abstract available


    November 2016
  50. KARAKOUSIS G, Gimotty PA, Bartlett EK, Sim MS, et al
    Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  51. LEE AY, Droppelmann N, Panageas KS, Zhou Q, et al
    Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  52. HAO H, Xiao D, Pan J, Qu J, et al
    Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  53. FAUT M, Wevers KP, van Ginkel RJ, Diercks GF, et al
    Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  54. KLEMEN ND, Feingold PL, Goff SL, Hughes MS, et al
    Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  55. ENGELHARDT KE, Wayne JD, Bilimoria KY
    Editorial: Should We Abandon TNM Staging in Favor of Gene Profiles in Node-Positive Melanoma?
    Ann Surg Oncol. 2016.
    PubMed     Text format    


    August 2016
  56. LOVASIK BP, Sharma I, Russell MC, Carlson GW, et al
    Invasive Scalp Melanoma: Role for Enhanced Detection Through Professional Training.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  57. BELLO DM, Han G, Jackson L, Bulloch K, et al
    The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  58. HEALY MA, Reynolds E, Banerjee M, Wong SL, et al
    Lymph Node Ratio Is Less Prognostic in Melanoma When Minimum Node Retrieval Thresholds Are Not Met.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  59. IPENBURG NA, Nieweg OE, Uren RF, Thompson JF, et al
    Outcome of Melanoma Patients Who Did Not Proceed to Sentinel Node Biopsy After Preoperative Lymphoscintigraphy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  60. MOSQUERA C, Vora HS, Vohra N, Fitzgerald TL, et al
    Population-Based Analysis of Completion Lymphadenectomy in Intermediate-Thickness Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  61. LINO-SILVA LS, Dominguez-Rodriguez JA, Aguilar-Romero JM, Martinez-Said H, et al
    Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  62. MADU MF, Wouters MW, Klop WM, van der Hiel B, et al
    Clinical Prognostic Markers in Stage IIIB Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  63. KANDA M, Shimizu D, Fujii T, Tanaka H, et al
    Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  64. LORIMER PD, White RL, Walsh K, Han Y, et al
    Pediatric and Adolescent Melanoma: A National Cancer Data Base Update.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  65. ANDTBACKA RH, Ross M, Puzanov I, Milhem M, et al
    Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  66. MINAMI CA, Wayne JD, Yang AD, Martini MC, et al
    National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality Measures.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  67. SONDAK VK, Messina JL
    Prediction is Difficult, Especially About the Future: Clinical Prognostic Tools in Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  68. BURKE EE, Portschy PR, Tuttle TM, Kuntz KM, et al
    Completion Lymph Node Dissection or Observation for Melanoma Sentinel Lymph Node Metastases: A Decision Analysis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  69. DAMUDE S, Hoekstra-Weebers JE, Francken AB, Ter Meulen S, et al
    The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  70. GE L, Vilain RE, Lo S, Aivazian K, et al
    Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  71. MAHAR AL, Compton C, Halabi S, Hess KR, et al
    Critical Assessment of Clinical Prognostic Tools in Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  72. CHAPMAN BC, Gleisner A, Kwak JJ, Hosokawa P, et al
    SPECT/CT Improves Detection of Metastatic Sentinel Lymph Nodes in Patients with Head and Neck Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  73. DOEPKER MP, Thompson ZJ, Fisher KJ, Yamamoto M, et al
    Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  74. CORDEIRO E, Gervais MK, Shah PS, Look Hong NJ, et al
    Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  75. DOSSETT LA, Ben-Shabat I, Olofsson Bagge R, Zager JS, et al
    Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  76. BAGGE AL, Ben-Shabat I, Belgrano V, Olofsson Bagge R, et al
    Erratum to: Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  77. VAN WISSEN J, van der Hiel B, van der Hage JA, van de Wiel BA, et al
    The Diagnostic Value of PET/CT Imaging in Melanoma Groin Metastases.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  78. ANNINGA B, White SH, Moncrieff M, Dziewulski P, et al
    Magnetic Technique for Sentinel Lymph Node Biopsy in Melanoma: The MELAMAG Trial.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  79. BAGGE AL, Ben-Shabat I, Belgrano V, Bagge RO, et al
    Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  80. EGGER ME, Kimbrough CW, Stromberg AJ, Quillo AR, et al
    Melanoma Patient-Reported Quality of Life Outcomes Following Sentinel Lymph Node Biopsy, Completion Lymphadenectomy, and Adjuvant Interferon: Results from the Sunbelt Melanoma Trial.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  81. BEN-SHABAT I, Belgrano V, Ny L, Nilsson J, et al
    Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  82. HUGHES MS, Zager J, Faries M, Alexander HR, et al
    Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  83. RIBERO S, Osella-Abate S, Pasquali S, Rossi CR, et al
    Prognostic Role of Multiple Lymphatic Basin Drainage in Sentinel Lymph Node-Negative Trunk Melanoma Patients: A Multicenter Study from the Italian Melanoma Intergroup.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  84. LEE DY, Huynh KT, Teng A, Lau BJ, et al
    Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  85. KROON HM, Coventry BJ, Giles MH, Henderson MA, et al
    Australian Multicenter Study of Isolated Limb Infusion for Melanoma.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  86. BRYS AK, Bhatti L, Bashir MR, Jaffe TA, et al
    Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  87. MACKENZIE ROSS AD, Haydu LE, Quinn MJ, Saw RP, et al
    The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  88. ROSS MI, Balch CM
    Excision Margins of Melanoma Make a Difference: New Data Support an Old Paradigm.
    Ann Surg Oncol. 2015.
    PubMed     Text format    


    October 2015
  89. GYORKI DE, Sanelli A, Herschtal A, Lazarakis S, et al
    Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  90. SMITH HG, Cartwright J, Wilkinson MJ, Strauss DC, et al
    Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor alpha for In-Transit Melanoma and Soft Tissue Sarcoma.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  91. DEPERALTA DK, Boland GM
    Melanoma: Advances in Targeted Therapy and Molecular Markers.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  92. BARTLETT EK, Peters MG, Blair A, Etherington MS, et al
    Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  93. COCHRAN AJ
    Identification, Clinical Significance, and Management of Very Small Melanoma Metastases in Sentinel Lymph Nodes.
    Ann Surg Oncol. 2015.
    PubMed     Text format    


  94. OUDE OPHUIS CM, van Akkooi AC, Hoekstra HJ, Bonenkamp JJ, et al
    Risk Factors for Positive Deep Pelvic Nodal Involvement in Patients with Palpable Groin Melanoma Metastases: Can the Extent of Surgery be Safely Minimized? : A Retrospective, Multicenter Cohort Study.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  95. HOLTKAMP LH, Wang S, Wilmott JS, Madore J, et al
    Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<0.1 mm) Sentinel Lymph Node Metastases.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  96. MEMARI N, Hayen A, Bell KJ, Rychetnik L, et al
    How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center?
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  97. HAYDU LE, Stollman JT, Scolyer RA, Spillane AJ, et al
    Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    March 2015
  98. GOTTLIEB M, Balk SJ, Geller AC, Gershenwald JE, et al
    Teens and indoor tanning: time to act on the US Food and Drug Administration's black-box warning.
    Ann Surg Oncol. 2015;22:701-3.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: